We are live on
!
Find out more
Royal London Asset Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+29.41%
3 Year Est. Return
+102.29%
5 Year Est. Return
+137.02%
10 Year Est. Return
–
AUM
$9.77B
AUM Growth
-$175M
(-1.8%)
Cap. Flow
-$808M
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
586
New
6
Increased
102
Reduced
329
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$173M |
| 2 |
Core Laboratories
CLB
|
+$170M |
| 3 |
Everest Group
EG
|
+$87.1M |
| 4 |
RenaissanceRe
RNR
|
+$70.9M |
| 5 |
Royal Caribbean
RCL
|
+$69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$161M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$109M |
| 3 |
Chevron
CVX
|
+$99.7M |
| 4 |
Verizon
VZ
|
+$89.4M |
| 5 |
Boeing
BA
|
+$77.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.99% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.32% |
| 4 | Consumer Discretionary | 13.05% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Northrop Grumman
NOC
$81.7B
| $20.5M | 0.21% |
64,610
-3,844
| -6% | -$1.17M |
|
102
Norfolk Southern
NSC
$75.2B
| $20.3M | 0.21% |
112,640
-5,499
| -5% | -$939K |
|
103
Progressive
PGR
$124B
| $19.8M | 0.2% |
279,030
+16,366
| +6% | +$1.05M |
|
104
Vertex Pharmaceuticals
VRTX
$134B
| $19.8M | 0.2% |
102,731
-2,358
| -2% | -$420K |
|
105
Valero Energy
VLO
$93B
| $19.7M | 0.2% |
173,396
-7,953
| -4% | -$903K |
|
|
TFCFA
106
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $19.6M | 0.2% |
422,305
-10,651
| -2% | -$488K |
|
107
Emerson Electric
EMR
$91.3B
| $19.4M | 0.2% |
252,945
-8,876
| -3% | -$655K |
|
108
American International
AIG
$40.6B
| $19.2M | 0.2% |
543,884
-14,072
| -3% | -$755K |
|
109
Humana
HUM
$45B
| $18.6M | 0.19% |
54,876
-2,657
| -5% | -$863K |
|
110
HCA Healthcare
HCA
$89.4B
| $18.3M | 0.19% |
131,297
+6,714
| +5% | +$836K |
|
111
Capital One
COF
$134B
| $18.2M | 0.19% |
192,133
-5,465
| -3% | -$532K |
|
112
Cognizant
CTSH
$26.3B
| $18.2M | 0.19% |
235,788
-5,790
| -2% | -$453K |
|
113
Illinois Tool Works
ITW
$83.7B
| $18.1M | 0.19% |
128,327
-1,275
| -1% | -$180K |
|
114
Zoetis
ZTS
$30.9B
| $17.8M | 0.18% |
194,076
-10,308
| -5% | -$914K |
|
115
LyondellBasell Industries
LYB
$20.7B
| $17.6M | 0.18% |
241,702
+108,388
| +81% | +$11.9M |
|
116
General Motors
GM
$78.2B
| $17.5M | 0.18% |
519,143
-18,574
| -3% | -$684K |
|
117
Southern Company
SO
$106B
| $17.5M | 0.18% |
400,432
-21,278
| -5% | -$981K |
|
118
Intercontinental Exchange
ICE
$84.6B
| $17.4M | 0.18% |
232,275
-9,622
| -4% | -$723K |
|
119
Agilent Technologies
A
$42.3B
| $17.3M | 0.18% |
244,684
+6,160
| +3% | +$408K |
|
|
EA
120
DELISTED
Electronic Arts
EA
| $17.2M | 0.18% |
142,857
-1,771
| -1% | -$228K |
|
121
Exelon
EXC
$46.3B
| $16.9M | 0.17% |
543,313
-13,655
| -2% | -$420K |
|
122
Steel Dynamics
STLD
$37.9B
| $16.9M | 0.17% |
374,046
+71,441
| +24% | +$3.29M |
|
123
Halliburton
HAL
$28.2B
| $16.4M | 0.17% |
403,606
+48,716
| +14% | +$2.02M |
|
124
Applied Materials
AMAT
$416B
| $16.3M | 0.17% |
421,174
-16,394
| -4% | -$725K |
|
125
Aflac
AFL
$61B
| $16.2M | 0.17% |
344,399
+3,163
| +0.9% | +$145K |
|
Similar funds
TI
RIM
LP
Royal London Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Royal London Asset Management held 586 positions worth $9.77B, down 1.8% from $9.94B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Royal London Asset Management withdrew a net $808M in Q3 2018, closing 73 positions and reducing 329 holdings. Its most notable exit was JPMorgan Chase, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Royal London Asset Management opened a new position in Abiomed Inc worth $7.25M.
- Royal London Asset Management's largest Q3 2018 buy was Abiomed Inc: 16,122 shares worth $7.25M.
- Royal London Asset Management added most to NXP Semiconductors in Q3 2018, an estimated $173M increase.
- Royal London Asset Management's biggest Q3 2018 reduction was Apple, cutting an estimated $24.5M.
- Royal London Asset Management fully exited JPMorgan Chase in Q3 2018, selling an estimated $161M.
- Royal London Asset Management's ten largest holdings make up 25% of its $9.77B portfolio in Q3 2018.
- Royal London Asset Management opened 6 new positions and closed 73 in Q3 2018.
- Royal London Asset Management's portfolio value fell 1.8% quarter-over-quarter to $9.77B.
Based on Royal London Asset Management's 13F filing for Q3 2018, filed 8 Nov 2018.